IS1624B - Forðaverkunar töflur sem innihalda Naproxen - Google Patents

Forðaverkunar töflur sem innihalda Naproxen

Info

Publication number
IS1624B
IS1624B IS4069A IS4069A IS1624B IS 1624 B IS1624 B IS 1624B IS 4069 A IS4069 A IS 4069A IS 4069 A IS4069 A IS 4069A IS 1624 B IS1624 B IS 1624B
Authority
IS
Iceland
Prior art keywords
naproxen
released
prolonged
release tablets
therapeutic
Prior art date
Application number
IS4069A
Other languages
English (en)
Other versions
IS4069A (is
Inventor
Marchi Egidio
Gabriele Rotini Leone
Original Assignee
Alfa Wassermann S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann S.P.A. filed Critical Alfa Wassermann S.P.A.
Publication of IS4069A publication Critical patent/IS4069A/is
Publication of IS1624B publication Critical patent/IS1624B/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IS4069A 1992-09-11 1993-09-01 Forðaverkunar töflur sem innihalda Naproxen IS1624B (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO920315A IT1258143B (it) 1992-09-11 1992-09-11 Compresse a cessione programmata contenenti naproxen

Publications (2)

Publication Number Publication Date
IS4069A IS4069A (is) 1994-03-12
IS1624B true IS1624B (is) 1996-10-18

Family

ID=11338458

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4069A IS1624B (is) 1992-09-11 1993-09-01 Forðaverkunar töflur sem innihalda Naproxen

Country Status (20)

Country Link
US (1) US5480650A (is)
EP (1) EP0587065B1 (is)
KR (1) KR970008157B1 (is)
CN (1) CN1088091A (is)
AT (1) ATE148340T1 (is)
AU (1) AU669552B2 (is)
CA (1) CA2105541C (is)
CZ (1) CZ279853B6 (is)
DE (1) DE69307807T2 (is)
DK (1) DK0587065T3 (is)
ES (1) ES2097952T3 (is)
FI (1) FI933975A (is)
GR (1) GR3022434T3 (is)
IL (1) IL106943A (is)
IS (1) IS1624B (is)
IT (1) IT1258143B (is)
MX (1) MX9305445A (is)
NO (1) NO304260B1 (is)
NZ (1) NZ248574A (is)
ZA (1) ZA936445B (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5609884A (en) * 1992-08-31 1997-03-11 G. D. Searle & Co. Controlled release naproxen sodium plus naproxen combination tablet
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6153225A (en) * 1998-08-13 2000-11-28 Elan Pharma International Limited Injectable formulations of nanoparticulate naproxen
US6165506A (en) * 1998-09-04 2000-12-26 Elan Pharma International Ltd. Solid dose form of nanoparticulate naproxen
JP2003520209A (ja) * 1999-12-16 2003-07-02 トライデント テクノロジーズ リミテッド ライアビリティ カンパニー 受容体負荷投与量を含む治療剤の長期送達システム及び方法
ATE546134T1 (de) * 2002-12-26 2012-03-15 Pozen Inc Mehrschichtige dosierformen enthaltend naproxen und triptane
NZ555693A (en) 2004-12-27 2010-10-29 Eisai R&D Man Co Ltd Matrix type sustained-release preparation containing donepezil
JP2011513391A (ja) * 2008-03-05 2011-04-28 パナセア バイオテック リミテッド ミコフェノラートを含有する徐放性医薬組成物およびその方法
US20090252791A1 (en) * 2008-04-02 2009-10-08 Venkata Nookaraju Sreedharala Pharmaceutical compositions comprising a triptan and a nonsteroidal anti-inflammatory drug
US20090311335A1 (en) * 2008-06-12 2009-12-17 Scott Jenkins Combination of a triptan and an nsaid
WO2009152551A1 (en) * 2008-06-20 2009-12-23 Alphapharm Pty Ltd Pharmaceutical formulation
CN113842362A (zh) 2012-11-14 2021-12-28 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1200178B (it) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
IT1215726B (it) * 1988-01-18 1990-02-22 Alfa Wassermann Spa Formulazioni galeniche a cessione programmata.
US5232705A (en) * 1990-08-31 1993-08-03 Alza Corporation Dosage form for time-varying patterns of drug delivery
US5204116A (en) * 1991-05-01 1993-04-20 Alza Corporation Dosage form providing immediate therapy followed by prolonged therapy

Also Published As

Publication number Publication date
DE69307807D1 (de) 1997-03-13
AU4620293A (en) 1994-03-17
NO933177D0 (no) 1993-09-07
NO304260B1 (no) 1998-11-23
FI933975A0 (fi) 1993-09-10
CZ180693A3 (en) 1994-03-16
ZA936445B (en) 1995-01-31
NO933177L (no) 1994-03-14
ATE148340T1 (de) 1997-02-15
CA2105541A1 (en) 1994-03-12
AU669552B2 (en) 1996-06-13
ES2097952T3 (es) 1997-04-16
DE69307807T2 (de) 1997-05-15
CA2105541C (en) 1999-01-05
CN1088091A (zh) 1994-06-22
IS4069A (is) 1994-03-12
EP0587065A1 (en) 1994-03-16
ITBO920315A1 (it) 1994-03-11
NZ248574A (en) 1995-04-27
KR970008157B1 (ko) 1997-05-21
KR940006577A (ko) 1994-04-25
CZ279853B6 (cs) 1995-07-12
GR3022434T3 (en) 1997-04-30
US5480650A (en) 1996-01-02
FI933975A (fi) 1994-03-12
MX9305445A (es) 1994-05-31
EP0587065B1 (en) 1997-01-29
DK0587065T3 (da) 1997-06-09
IL106943A (en) 1998-09-24
IT1258143B (it) 1996-02-20
ITBO920315A0 (it) 1992-09-11

Similar Documents

Publication Publication Date Title
RU98111594A (ru) Фармацевтические композиции, включающие флурбипрофен
GR3007312T3 (is)
NO20022014D0 (no) Kontrollert frigjöring av hydrocodone formuleringer
GR3015027T3 (en) Sustained release compositions for treating periodontal disease.
EP0418596A3 (en) Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
IS4069A (is) Forðaverkunar töflur sem innihalda Naproxen
NZ236112A (en) Sustained release compositions for treating periodontal disease
DE69803670D1 (de) Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung